Abstract
Introduction Rotator cuff degeneration is considered to be a major factor in the pathogenesis of rotator cuff tendon tear. Degenerative weakening of the rotator cuff can result in irreversible complete cuff-tear arthropathy syndrome. Recently a porcine small intestinal submucosa (SIS) has been approved by TGA as biological implant for the repair of rotator cuff tendon tear. The aims of this study are to evaluate the safety and efficacy of SIS.
Methods A commercial brand of SIS was examined by histology and PCR technique. The material was implanted into mice and rabbits for the evaluation of biological reaction and inflammatory response. Next, we have used SIS to replace the rotator cuff tendon in rabbit (N=10) and compared to control (N=10). Histological examination was conducted at four and eight weeks after implantation. To further confirm if cells present in SIS material were of porcine origin, nested PCR for the amplification of DAP12 gene was used.
Results Fresh SIS membrane before implantation contain multiple layers of spindle-shaped cells mixed with a small population of round-shaped cells. Chloroacetate esterase staining showed that the round-shaped cells are positive, indicating that they are mast cells. The tissue architecture of SIS mimics tendon structure as evidenced by H & E staining. The SIS membrane contained porcine DNA materials. Subcutaneous implant of SIS in mice (by six) for up to seven days showed no obvious inflammatory response or foreign body reaction. The result demonstrated that SIS has remained in the region and mixed with regenerative fibrous tissue after eight weeks. In some cases there was a massive recruitment of lymphocytes along the surface of membrane. However, no foreign body reactive giant cells were observed.
Conclusions The result of this study indicated that SIS contains porcine cells and nucleic acid, which contradicts current views that SIS is a cell free biomaterial. Although no foreign body reaction of SIS was observed, SIS implant may cause chronic inflammation. Further studies should be conducted to confirm the clinical efficacy of SIS implant for rotator cuff tendon tear.
The abstracts were prepared by Mr Jerzy Sikorski. Correspondence should be addressed to him at the Australian Orthopaedic Association, Ground Floor, William Bland Centre, 229 Macquarie Street, Sydney NSW 2000, Australia.
None of the authors have received any payment or consideration from any source for the conduct of this study.
